The HIST1H4A (Ab-88) Antibody is a polyclonal antibody targeting the tyrosine 88 (Y88) residue of human histone H4, a core component of nucleosomes. Histone H4 plays a central role in chromatin structure, gene regulation, and epigenetic modifications such as acetylation and methylation . This antibody is specifically designed to study post-translational modifications (PTMs) at this site, which influence DNA accessibility and cellular processes like transcription and DNA repair .
Detects histone H4 modifications in formalin-fixed, paraffin-embedded human tissues .
Example: Staining of breast adenocarcinoma sections showed nuclear localization, validated using EDTA antigen retrieval and HRP-conjugated secondary antibodies .
Specificity: Blocking experiments with Y88-containing peptides confirm minimal cross-reactivity .
Batch Consistency: Antigen affinity purification ensures high lot-to-lot reproducibility .
Negative Controls: PBS instead of primary antibody or isotype-matched IgG showed no background staining .
HIST1H4A is a histone H4 family member that plays critical roles in chromatin structure and gene regulation. The tyrosine 88 (Tyr88) residue in histone H4 is evolutionarily conserved, suggesting an important physiological function . Phosphorylation at this site (pY88-H4) has been identified in multiple castration-resistant prostate cancer (CRPC) biospecimens, indicating its potential role in disease progression . This post-translational modification appears to be involved in regulating androgen receptor (AR) gene expression, making it particularly relevant for prostate cancer research .
The specificity of HIST1H4A (Ab-88) Antibody is validated through multiple complementary approaches:
Peptide competition assays - The antibody specifically recognizes Tyr88-phosphorylated H4 peptide but not unphosphorylated peptide
Cross-reactivity screening - Testing against 59 different histone modifications (acetylation, methylation, phosphorylation, and citrullination) using Histone Peptide Array demonstrates no cross-reactivity
Mutation studies - Point mutant constructs (Y88F-H4 and Y72F-H4) confirm that the antibody specifically recognizes phosphorylation at the Tyr88 site but not at Tyr72
Western blotting - Direct immunoblotting and immunofluorescence analyses further validate specificity
For optimal detection of histone H4 phosphorylation at Tyr88, the following protocols are recommended:
Histone Purification: Total histones should be purified from cells or tissues using acid extraction methods
Cell Treatment: For stimulation studies, serum and androgen starvation followed by growth factor treatment (e.g., insulin-like growth factor or platelet-derived growth factor) can induce robust phosphorylation
Protein Extraction: For immunoblotting applications, standard cell lysis and nuclear extraction protocols are appropriate with the addition of phosphatase inhibitors to preserve phosphorylation status
ChIP Sample Preparation: For chromatin immunoprecipitation applications, standard crosslinking procedures followed by sonication to generate chromatin fragments of appropriate size (~200-500bp) are recommended
HIST1H4A (Ab-88) Antibody has been successfully employed in ChIP-seq experiments to map the genome-wide distribution of pY88-H4 marks. Based on published research methodologies:
Immunoprecipitation Protocol: The antibody can be used to immunoprecipitate chromatin fragments containing the pY88-H4 mark
Sequencing Depth: For comprehensive coverage, high-depth sequencing is recommended (~20-30 million uniquely mapped reads)
Data Analysis: The resulting data can identify distinct genomic locations where pY88-H4 marks are deposited (e.g., upstream of the AR transcription start site)
Validation: ChIP-qPCR with site-specific primers should be used to validate key findings from ChIP-seq data
Research using this approach has identified approximately 370 distinct genomic locations with pY88-H4 deposition, including specific regions upstream of the AR gene that appear critical for its transcriptional regulation .
Evidence from multiple experimental approaches demonstrates that ACK1 (TNK2) is the primary kinase responsible for phosphorylating histone H4 at Tyr88:
Mass Spectrometry Analysis: Total histones purified from cells expressing activated ACK1 show Tyr88 phosphorylation, while histones from SRC-expressing cells do not
Protein Interaction: Pull-down studies followed by mass spectrometry reveal that ACK1 (phosphorylated at Tyr827) binds directly to histone H4
In Vitro Kinase Assay: Purified recombinant human ACK1 directly phosphorylates histone H4 at Tyr88 in cell-free conditions, and this activity is inhibited by ACK1 inhibitor (R)-9bMS
Specificity Testing: When incubated with all four core histones, ACK1 specifically phosphorylates H4 but not H2A, H2B, or H3
Knockdown Studies: siRNA-mediated knockdown or CRISPR-Cas9 deletion of ACK1 significantly reduces H4 Tyr88 phosphorylation
The phosphorylation of histone H4 at Tyr88 appears to play a critical role in gene regulation, particularly for the androgen receptor (AR) gene:
Chromatin Marking: ChIP-seq analysis reveals that pY88-H4 marks are deposited at specific locations upstream of the AR transcription start site, termed AR enhancer modules (AREMs)
Transcriptional Activation: The deposition of pY88-H4 marks is associated with increased AR gene expression
Mechanism: The pY88-H4 mark appears to promote recruitment of the WDR5/MLL2 complex, which likely contributes to transcriptional activation
Functional Consequence: Mutation studies using the Y88F mutant of H4 demonstrate that this phosphorylation site is necessary for AR upregulation, as expression of the non-phosphorylatable mutant results in decreased AR and PSA mRNA levels
Disease Relevance: The pY88-H4 mark has been identified in castration-resistant prostate cancer samples but not in normal prostate tissue, suggesting its potential role in disease progression
To ensure robust and reproducible results when using HIST1H4A (Ab-88) Antibody, the following controls should be included:
Peptide Competition: Pre-incubation of the antibody with phosphopeptide should abolish signal
Kinase Inhibition: Treatment with ACK1 inhibitor ((R)-9bMS) should reduce pY88-H4 signal
Genetic Controls: Cells expressing Y88F mutant H4 should show negative results
Positive Controls: Cells treated with growth factors known to activate ACK1 (e.g., IGF, PDGF) should show increased signal
Knockdown Controls: ACK1 knockdown or knockout cells should show reduced signal
Isotype Control: Use of an isotype-matched non-specific antibody to assess background binding
Technical Replicates: Multiple replicates to ensure reproducibility
HIST1H4A (Ab-88) Antibody can be effectively combined with other methodologies to provide comprehensive insights into chromatin structure and function:
HiChIP Applications: The antibody can potentially be used in HiChIP experiments to identify chromatin interactions associated with pY88-H4 marks, similar to approaches used with other histone modifications like H3K27ac
Multi-omics Integration: Data from pY88-H4 ChIP-seq can be integrated with RNA-seq, ATAC-seq, and other histone modification ChIP-seq datasets to comprehensively map the regulatory landscape
Allele-Specific Analysis: For studies involving genetic variants, the antibody could be used to assess allele-specific deposition of pY88-H4 marks, potentially contributing to interaction QTL (iQTL) studies
Time-Course Experiments: The antibody can be used to monitor dynamic changes in pY88-H4 deposition following various stimuli, providing insights into temporal regulation
While the HIST1H4A (Ab-88) Antibody has been shown to be highly specific, researchers should consider the following strategies to address potential cross-reactivity concerns:
Histone Peptide Array: Comprehensive testing against multiple histone modifications to confirm specificity
Point Mutation Studies: Expression of mutant histones (e.g., Y88F-H4) as negative controls
Comparison with Total H4: Parallel analysis with antibodies against unmodified H4 to normalize for total H4 levels
Multiple Antibody Validation: Confirmation of key findings using alternative antibodies or detection methods when available
Mass Spectrometry Validation: For critical findings, mass spectrometry-based validation of the modification can provide definitive evidence
For accurate quantification of pY88-H4 levels:
Western Blot Quantification: Normalization to total H4 levels is essential for comparative analysis
ChIP-qPCR: Standard curves should be generated for accurate quantification, with normalization to input DNA
ChIP-seq Analysis: Quantification of peak heights or areas using appropriate bioinformatic tools, with normalization to sequencing depth and input controls
Statistical Analysis: Multiple biological replicates (minimum n=3) should be used for statistical comparisons
Dose-Response Studies: For treatment effects, full dose-response curves rather than single-dose experiments provide more robust quantification
Distinguishing direct from indirect effects requires multiple complementary approaches:
Temporal Analysis: Time-course experiments to determine the sequence of events following stimulation
Proximity Analysis: ChIP-seq combined with RNA-seq to correlate pY88-H4 deposition with changes in nearby gene expression
Perturbation Studies: Targeted disruption of the modification (e.g., by expressing Y88F-H4 mutant) coupled with gene expression analysis
Mechanistic Studies: Investigation of protein complexes recruited to pY88-H4 marks using techniques like ChIP-MS or protein-protein interaction studies
Functional Genomics: CRISPR-based editing of potential pY88-H4 binding sites to assess functional consequences
Recent advances in chromatin interaction studies suggest several potential applications:
HiChIP Applications: The antibody could be used for HiChIP experiments to identify chromatin loops associated with pY88-H4 marks, similar to approaches using H3K27ac HiChIP
Interaction QTL Studies: Integration with genotype data could identify genetic variants associated with pY88-H4-mediated chromatin interactions
Cell Type-Specific Interactions: Comparison of pY88-H4-associated chromatin loops across different cell types could reveal tissue-specific regulatory mechanisms
Dynamic Reorganization: Analysis of changes in pY88-H4-associated loops in response to stimuli could provide insights into dynamic genome reorganization
Understanding the interplay between pY88-H4 and other histone modifications represents an important research direction:
Co-occurrence Analysis: ChIP-seq for multiple modifications to identify patterns of co-occurrence or mutual exclusivity
Sequential ChIP: Sequential ChIP experiments (Re-ChIP) to determine if pY88-H4 co-exists with other modifications on the same nucleosomes
Enzymatic Crosstalk: Investigation of how pY88-H4 might influence the activity of other histone-modifying enzymes
Modification Readers: Identification of proteins that specifically recognize pY88-H4 and how they might interact with readers of other modifications
Integrative Analysis: Computational integration of multiple histone modification datasets to identify combinatorial patterns associated with specific gene expression states